Clinical Trial Update: Effect of Zydena (Udenafil) on Cerebral Blood Flow and Peripheral Blood Viscosity [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial studied udenafil (Zydena) for its effects on cerebral blood flow and peripheral blood viscosity in vascular dementia and subcortical va…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subcortical Vascular Dementia
• Vascular Dementia

Drugs mentioned

• Zydena (udenafil)

Snippet

Sponsor: Samsung Medical Center | Conditions: Vascular Dementia, Subcortical Vascular Dementia | Phase 2 | Status: UNKNOWN